Literature DB >> 24789686

Major histocompatibility complex class II deficiency complicated by Mycobacterium avium complex in a boy of mixed ethnicity.

Dimana Dimitrova1, Peck Y Ong, Maurice R G O'Gorman, Joseph A Church.   

Abstract

Major histocompatibility complex class II (MHCII) deficiency represents a rare form of severe immunodeficiency associated with increased susceptibility to viral, bacterial, and fungal pathogens and commonly leads to failure to thrive and early death. This autosomal recessive disorder is caused by mutations in MHCII transcription regulator genes, resulting in impaired expression of MHCII, and it is usually seen in consanguineous populations. Our patient presented at age 15 months with a history of developmental delay, multiple respiratory infections and skin abscesses, and recently, at 5 years of age, he was found to have disseminated Mycobacterium avium complex. His mother is Mexican-American, and his father is Persian. Laboratory investigations showed hypogammaglobulinemia, modest T-lymphopenia, borderline mitogen responses, absent tetanus toxoid and candida antigen lymphoproliferative assays, and absent tetanus toxoid and Haemophilus influenzae type b antibody levels. Flow cytometry demonstrated absent HLA-DR antigen on monocytes and B-cells, and a diagnosis of MHCII deficiency was made. Genetic analysis yielded a homozygous pathogenic class II transactivator (CIITA) mutation. The same mutation was found in both parents. Coincidently, an Xq28 microduplication was identified and likely was the cause of the patient's developmental delay. This patient demonstrated some of the typical features of MHCII deficiency with the addition of several unique findings: disseminated M. avium complex, homozygosity in a CIITA mutation despite remarkably diverse parental ethnicity, and coincident Xq28 microdeletion with mild intellectual disability.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24789686     DOI: 10.1007/s10875-014-0048-x

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  18 in total

Review 1.  The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes.

Authors:  A DeSandro; U M Nagarajan; J M Boss
Journal:  Am J Hum Genet       Date:  1999-08       Impact factor: 11.025

2.  A case of chronic granulomatous skin disease associated with deficient HLA class I expression.

Authors:  G Mertens; D Desmet; M Gielis
Journal:  Br J Dermatol       Date:  2000-09       Impact factor: 9.302

3.  Int22h-1/int22h-2-mediated Xq28 rearrangements: intellectual disability associated with duplications and in utero male lethality with deletions.

Authors:  Ayman W El-Hattab; Ping Fang; Weihong Jin; Jeffrey R Hughes; James B Gibson; Gayle S Patel; Dorothy K Grange; Linda P Manwaring; Ankita Patel; Pawel Stankiewicz; Sau Wai Cheung
Journal:  J Med Genet       Date:  2011-10-08       Impact factor: 6.318

Review 4.  Regulation of MHC class II gene expression by the class II transactivator.

Authors:  Walter Reith; Salomé LeibundGut-Landmann; Jean-Marc Waldburger
Journal:  Nat Rev Immunol       Date:  2005-10       Impact factor: 53.106

5.  Clinical course of patients with major histocompatibility complex class II deficiency.

Authors:  M A Saleem; P D Arkwright; E G Davies; A J Cant; P A Veys
Journal:  Arch Dis Child       Date:  2000-10       Impact factor: 3.791

6.  Subcutaneous Panniculitis-like T-cell lymphoma in two pediatric patients: an HIV-positive adolescent and a 4-month-old infant.

Authors:  Sara C Acree; Jason P Tovar; Paul K Pattengale; Larry L Wang; Joseph A Church; Paul S Gaynon; David S Cassarino
Journal:  Fetal Pediatr Pathol       Date:  2012-10-23       Impact factor: 0.958

7.  Four unrelated patients with Lubs X-linked mental retardation syndrome and different Xq28 duplications.

Authors:  Oliver Bartsch; Konstanze Gebauer; Stanislav Lechno; Hilde van Esch; Guy Froyen; Michael Bonin; Jörg Seidel; Barbara Thamm-Mücke; Denise Horn; Eva Klopocki; Christoph Hertzberg; Ulrich Zechner; Thomas Haaf
Journal:  Am J Med Genet A       Date:  2010-02       Impact factor: 2.802

8.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

9.  Susceptibility of mice deficient in the MHC class II transactivator to infection with Mycobacterium tuberculosis.

Authors:  C J Repique; A Li; W J Brickey; J P Y Ting; F M Collins; S L Morris
Journal:  Scand J Immunol       Date:  2003-07       Impact factor: 3.487

10.  Autosomal dominant and sporadic monocytopenia with susceptibility to mycobacteria, fungi, papillomaviruses, and myelodysplasia.

Authors:  Donald C Vinh; Smita Y Patel; Gulbu Uzel; Victoria L Anderson; Alexandra F Freeman; Kenneth N Olivier; Christine Spalding; Stephen Hughes; Stefania Pittaluga; Mark Raffeld; Lynn R Sorbara; Houda Z Elloumi; Douglas B Kuhns; Maria L Turner; Edward W Cowen; Danielle Fink; Debra Long-Priel; Amy P Hsu; Li Ding; Michelle L Paulson; Adeline R Whitney; Elizabeth P Sampaio; David M Frucht; Frank R DeLeo; Steven M Holland
Journal:  Blood       Date:  2009-12-29       Impact factor: 22.113

View more
  2 in total

1.  Treatment of infants identified as having severe combined immunodeficiency by means of newborn screening.

Authors:  Morna J Dorsey; Christopher C Dvorak; Morton J Cowan; Jennifer M Puck
Journal:  J Allergy Clin Immunol       Date:  2017-03       Impact factor: 10.793

Review 2.  Inherited and acquired immunodeficiencies underlying tuberculosis in childhood.

Authors:  Stéphanie Boisson-Dupuis; Jacinta Bustamante; Jamila El-Baghdadi; Yildiz Camcioglu; Nima Parvaneh; Safaa El Azbaoui; Aomar Agader; Amal Hassani; Naima El Hafidi; Nidal Alaoui Mrani; Zineb Jouhadi; Fatima Ailal; Jilali Najib; Ismail Reisli; Adil Zamani; Sebnem Yosunkaya; Saniye Gulle-Girit; Alisan Yildiran; Funda Erol Cipe; Selda Hancerli Torun; Ayse Metin; Basak Yildiz Atikan; Nevin Hatipoglu; Cigdem Aydogmus; Sara Sebnem Kilic; Figen Dogu; Neslihan Karaca; Guzide Aksu; Necil Kutukculer; Melike Keser-Emiroglu; Ayper Somer; Gonul Tanir; Caner Aytekin; Parisa Adimi; Seyed Alireza Mahdaviani; Setareh Mamishi; Aziz Bousfiha; Ozden Sanal; Davood Mansouri; Jean-Laurent Casanova; Laurent Abel
Journal:  Immunol Rev       Date:  2015-03       Impact factor: 12.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.